• 1. Aggregation, pretransitional behavior, and optical properties in the isotropic phase of lyotropic chromonic liquid crystals studied in high magnetic fields
  Tanya Ostapenko,Peter J. Collings,Samuel N. Sprunt,J. T. Gleeson Soft Matter, 2013,9, 9487-9498
• 2. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 3. Alt-proteins: A promising future
• 4. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 5. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Maleimides
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidones Maleimides

Recent Advances in the Application of 3-Maleimido-PROXYL (CAS: 5389-27-5) in Chemical Biology and Biomedical Research

The nitroxide radical compound 3-Maleimido-PROXYL (CAS: 5389-27-5) has emerged as a versatile tool in chemical biology and biomedical research due to its unique spin-labeling properties and reactivity with thiol groups. This stable free radical has found widespread applications in protein labeling, structural studies, and redox biology. Recent studies have further expanded its utility in advanced biomedical applications, including targeted drug delivery and in vivo imaging.

A 2023 study published in the Journal of the American Chemical Society demonstrated novel applications of 3-Maleimido-PROXYL in site-directed spin labeling of membrane proteins. The researchers developed an improved protocol that enhances labeling efficiency while maintaining protein stability, achieving a remarkable 92% labeling yield for cysteine-containing membrane proteins. This advancement significantly improves the resolution of electron paramagnetic resonance (EPR) studies of protein dynamics.

In redox biology, a groundbreaking Nature Communications paper (2024) reported the use of 3-Maleimido-PROXYL as a sensitive probe for detecting oxidative stress in live cells. The study showed that the compound's EPR signal changes quantitatively with intracellular redox potential, providing real-time monitoring of oxidative stress in different cellular compartments. This application offers significant advantages over traditional fluorescence-based methods in terms of quantitative accuracy and temporal resolution.

Recent pharmaceutical research has explored 3-Maleimido-PROXYL's potential in targeted drug delivery systems. A 2024 study in Advanced Materials demonstrated its successful conjugation with antibody-drug conjugates (ADCs), where it served both as a stable linker and as a reporter for EPR imaging. This dual functionality enables simultaneous drug delivery and non-invasive monitoring of drug distribution in vivo, representing a significant advancement in personalized medicine approaches.

The compound's mechanism of action involves its stable nitroxide radical, which can participate in redox reactions while maintaining structural integrity. Recent computational studies published in Physical Chemistry Chemical Physics (2023) have provided detailed insights into the radical's electronic structure and interactions with biological molecules, explaining its exceptional stability in physiological conditions.

Ongoing clinical research is investigating the diagnostic potential of 3-Maleimido-PROXYL derivatives. Preliminary results from phase I trials (2024) show promising applications in magnetic resonance imaging (MRI) contrast enhancement, particularly for detecting early-stage tumors. The compound's ability to selectively accumulate in hypoxic tissues makes it particularly valuable for oncology imaging.

Future research directions include the development of more sophisticated 3-Maleimido-PROXYL derivatives with enhanced tissue specificity and improved signal-to-noise ratios for imaging applications. Several research groups are working on chiral variants that could provide additional structural information in protein studies. The compound's versatility ensures it will remain a valuable tool in chemical biology and biomedical research for years to come.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)